Jeffrey Farrow
2018 - Global Blood Therapeutics
In 2018, Jeffrey Farrow earned a total compensation of $3.3M as Chief Financial Officer at Global Blood Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $201,000 |
|---|---|
| Option Awards | $1,326,469 |
| Salary | $425,938 |
| Stock Awards | $1,370,800 |
| Other | $5,000 |
| Total | $3,329,207 |
Farrow received $1.4M in stock awards, accounting for 41% of the total pay in 2018.
Farrow also received $201K in non-equity incentive plan, $1.3M in option awards, $425.9K in salary and $5K in other compensation.
Rankings
In 2018, Jeffrey Farrow's compensation ranked 3,455th out of 14,244 executives tracked by ExecPay. In other words, Farrow earned more than 75.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,455 out of 14,244 | 76th |
Division Manufacturing | 1,276 out of 5,759 | 78th |
Major group Chemicals And Allied Products | 445 out of 2,122 | 79th |
Industry group Drugs | 367 out of 1,811 | 80th |
Industry Pharmaceutical Preparations | 280 out of 1,385 | 80th |
Source: SEC filing on April 28, 2021.
Farrow's colleagues
We found four more compensation records of executives who worked with Jeffrey Farrow at Global Blood Therapeutics in 2018.